Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Uber Technologies announced new products and features at its annual Go-Get product event, including hotel bookings and travel tools that are planned to roll out globally in the coming months.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.